Turmeric and Pomalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Turmeric (turmeric) and Pomalidomide (pomalidomide). Common drug interactions include asthenia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Turmeric and Pomalidomide. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Turmeric?

Turmeric has active ingredients of turmeric. It is often used in inflammation. eHealthMe is studying from 16,564 Turmeric users. Check the latest studies of Turmeric.

What is Pomalidomide?

Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

20 people who take Turmeric and Pomalidomide together, and have interactions are studied.

Turmeric and Pomalidomide drug interactions.

What are the common drug interactions of Turmeric and Pomalidomide, by gender? *:

female:

  1. Asthenia (weakness)
  2. Plasma cell myeloma (cancer that begins in plasma cells)
  3. Platelet count decreased
  4. Actinic keratosis (skin disease due to sun exposure)
  5. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  6. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
  7. Seborrhoeic keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest)
  8. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  9. Adverse event
  10. Arthralgia (joint pain)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Peripheral swelling
  5. Platelet count decreased
  6. Pyrexia (fever)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Weight decreased
  9. Troponin i increased
  10. Asthenia (weakness)

What are the common drug interactions of Turmeric and Pomalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Arthralgia (joint pain)
  2. Fatigue (feeling of tiredness)
  3. Muscle tightness

50-59:

  1. Febrile neutropenia (fever with reduced white blood cells)

60+:

  1. Platelet count decreased
  2. Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Back pain
  5. Burning sensation
  6. Conjunctivitis (pink eye)
  7. Fatigue (feeling of tiredness)
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  10. Metastases to bone (cancer spreads to bone)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 20 people, 100.00%
  2. Diarrhea: 4 people, 20.00%
  3. Allergic Rhinitis: 4 people, 20.00%
  4. Allergies: 4 people, 20.00%
  5. Insomnia (sleeplessness): 4 people, 20.00%
  6. High Blood Pressure: 4 people, 20.00%
  7. High Blood Cholesterol: 4 people, 20.00%
  8. Back Pain: 4 people, 20.00%
  9. Depression: 4 people, 20.00%
  10. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Turmeric and Pomalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Turmeric and Pomalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Turmeric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pomalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Turmeric and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pomalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on turmeric and pomalidomide (the active ingredients of Turmeric and Pomalidomide, respectively), and Turmeric and Pomalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: